cloudfront

Report Detail



Pharma & HealthcareGlobal Drugs for Oral Mucositis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414347
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 120 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Drugs for Oral Mucositis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Drugs for Oral Mucositis Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Mouthwash
  • 1.2.2 Pain Control Medication
  • 1.2.3 Other
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospitals
  • 1.3.2 Dental Clinics
  • 1.3.3 Others
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 3M Healthcare
    • 2.1.1 Business Overview
  • 2.1.2 Drugs for Oral Mucositis Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 3M Healthcare Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 GSK
  • 2.2.1 Business Overview
  • 2.2.2 Drugs for Oral Mucositis Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 GSK Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Drugs for Oral Mucositis Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Pfizer Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Colgate-Palmolive
  • 2.4.1 Business Overview
  • 2.4.2 Drugs for Oral Mucositis Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Colgate-Palmolive Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Norgine
  • 2.5.1 Business Overview
  • 2.5.2 Drugs for Oral Mucositis Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Norgine Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Biovitrum
  • 2.6.1 Business Overview
  • 2.6.2 Drugs for Oral Mucositis Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Biovitrum Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Valeant Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Drugs for Oral Mucositis Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Valeant Pharmaceuticals Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 EUSA Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Drugs for Oral Mucositis Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 EUSA Pharma Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Camurus
  • 2.9.1 Business Overview
  • 2.9.2 Drugs for Oral Mucositis Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Camurus Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Mission Pharmacal
  • 2.10.1 Business Overview
  • 2.10.2 Drugs for Oral Mucositis Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Mission Pharmacal Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.11 Clinigen Group
  • 2.11.1 Business Overview
  • 2.11.2 Drugs for Oral Mucositis Type and Applications
  • 2.11.2.1 Product A
  • 2.11.2.2 Product B
  • 2.11.3 Clinigen Group Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.12 Midatech Pharma
  • 2.12.1 Business Overview
  • 2.12.2 Drugs for Oral Mucositis Type and Applications
  • 2.12.2.1 Product A
  • 2.12.2.2 Product B
  • 2.12.3 Midatech Pharma Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.13 Alliance Pharma
  • 2.13.1 Business Overview
  • 2.13.2 Drugs for Oral Mucositis Type and Applications
  • 2.13.2.1 Product A
  • 2.13.2.2 Product B
  • 2.13.3 Alliance Pharma Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.14 AMAG Pharmaceuticals
  • 2.14.1 Business Overview
  • 2.14.2 Drugs for Oral Mucositis Type and Applications
  • 2.14.2.1 Product A
  • 2.14.2.2 Product B
  • 2.14.3 AMAG Pharmaceuticals Drugs for Oral Mucositis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Drugs for Oral Mucositis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Drugs for Oral Mucositis Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Drugs for Oral Mucositis Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Drugs for Oral Mucositis Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Drugs for Oral Mucositis Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Drugs for Oral Mucositis Market Analysis by Regions

    • 4.1 Global Drugs for Oral Mucositis Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Drugs for Oral Mucositis Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Drugs for Oral Mucositis Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 4.3 Europe Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 4.5 South America Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 5 North America Drugs for Oral Mucositis by Countries

    • 5.1 North America Drugs for Oral Mucositis Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Drugs for Oral Mucositis Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Drugs for Oral Mucositis Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 5.3 Canada Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 6 Europe Drugs for Oral Mucositis by Countries

    • 6.1 Europe Drugs for Oral Mucositis Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Drugs for Oral Mucositis Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Drugs for Oral Mucositis Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 6.3 UK Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 6.4 France Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 6.5 Russia Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 6.6 Italy Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Drugs for Oral Mucositis by Countries

    • 7.1 Asia-Pacific Drugs for Oral Mucositis Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Drugs for Oral Mucositis Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Drugs for Oral Mucositis Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 7.3 Japan Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 7.4 Korea Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 7.5 India Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 8 South America Drugs for Oral Mucositis by Countries

    • 8.1 South America Drugs for Oral Mucositis Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Drugs for Oral Mucositis Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Drugs for Oral Mucositis Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Drugs for Oral Mucositis by Countries

    • 9.1 Middle East and Africa Drugs for Oral Mucositis Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Drugs for Oral Mucositis Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Drugs for Oral Mucositis Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 9.3 UAE Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Drugs for Oral Mucositis Sales and Growth Rate (2013-2018)
  • 10 Global Drugs for Oral Mucositis Market Segment by Type

    • 10.1 Global Drugs for Oral Mucositis Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Drugs for Oral Mucositis Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Drugs for Oral Mucositis Revenue and Market Share by Type (2013-2018)
  • 10.2 Mouthwash Sales Growth and Price
  • 10.2.1 Global Mouthwash Sales Growth (2013-2018)
  • 10.2.2 Global Mouthwash Price (2013-2018)
  • 10.3 Pain Control Medication Sales Growth and Price
  • 10.3.1 Global Pain Control Medication Sales Growth (2013-2018)
  • 10.3.2 Global Pain Control Medication Price (2013-2018)
  • 10.4 Other Sales Growth and Price
  • 10.4.1 Global Other Sales Growth (2013-2018)
  • 10.4.2 Global Other Price (2013-2018)
  • 11 Global Drugs for Oral Mucositis Market Segment by Application

    • 11.1 Global Drugs for Oral Mucositis Sales Market Share by Application (2013-2018)
    • 11.2 Hospitals Sales Growth (2013-2018)
    • 11.3 Dental Clinics Sales Growth (2013-2018)
    • 11.4 Others Sales Growth (2013-2018)

    12 Drugs for Oral Mucositis Market Forecast (2018-2023)

    • 12.1 Global Drugs for Oral Mucositis Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Drugs for Oral Mucositis Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Drugs for Oral Mucositis Market Forecast (2018-2023)
  • 12.2.2 Europe Drugs for Oral Mucositis Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Drugs for Oral Mucositis Market Forecast (2018-2023)
  • 12.2.4 South America Drugs for Oral Mucositis Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Drugs for Oral Mucositis Market Forecast (2018-2023)
  • 12.3 Drugs for Oral Mucositis Market Forecast by Type (2018-2023)
  • 12.3.1 Global Drugs for Oral Mucositis Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Drugs for Oral Mucositis Market Share Forecast by Type (2018-2023)
  • 12.4 Drugs for Oral Mucositis Market Forecast by Application (2018-2023)
  • 12.4.1 Global Drugs for Oral Mucositis Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Drugs for Oral Mucositis Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.

      Scope of the Report:

      This report focuses on the Drugs for Oral Mucositis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017.

      Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017.

      The worldwide market for Drugs for Oral Mucositis is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers

      3M Healthcare

      GSK

      Pfizer

      Colgate-Palmolive

      Norgine

      Biovitrum

      Valeant Pharmaceuticals

      EUSA Pharma

      Camurus

      Mission Pharmacal

      Clinigen Group

      Midatech Pharma

      Alliance Pharma

      AMAG Pharmaceuticals

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Mouthwash

      Pain Control Medication

      Other

      Market Segment by Applications, can be divided into

      Hospitals

      Dental Clinics

      Others

      There are 15 Chapters to deeply display the global Drugs for Oral Mucositis market.

      Chapter 1, to describe Drugs for Oral Mucositis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Drugs for Oral Mucositis, with sales, revenue, and price of Drugs for Oral Mucositis, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Oral Mucositis, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Drugs for Oral Mucositis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Drugs for Oral Mucositis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Drugs for Oral Mucositis . Industry analysis & Market Report on Drugs for Oral Mucositis is a syndicated market report, published as Global Drugs for Oral Mucositis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Drugs for Oral Mucositis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report